Building an Interoperable Rare Disease Multi-omic Resource: The GREGoR Data Model and Dataset
Ben HeavneriD, Marsha M. WheeleriD, Jesse D. BengtssoniD, Claudia M.B. CarvalhoiD, Warren CheungiD, Matthew P. ConomosiD, Emmanuèle C. DélotiD, Stephanie P. DiTroiaiD, Vijay S GaneshiD, Stephanie M. GogarteniD, Christopher M. GrochowskiiD, Shalini N. JhangianiiD, Charles Hadley S. KingiD, Cas LeMasteriD, Colby T. MarviniD, Shruti MarwahaiD, Danny E. MilleriD, Anne O’Donnell‐LuriaiD, Lynn S. PaisiD, Karynne PattersoniD, Guanghao QiiD, Matthew A. RichardsoniD, Craig SmailiD, Adrienne M. StilpiD, Catherine Tong, , Jessica X. ChongiD
Abstract
Rare disease research and diagnosis rely on the integration of genomic and phenotypic data generated across diverse clinical sites; however, the absence of widely adopted standards for representing genomic data and associated metadata has limited data interoperability, reuse, and cross-study analysis. The Genomics Research to Elucidate the Genetics of Rare Diseases (GREGoR) Consortium was established to investigate challenging rare disease cases and evaluate emerging multi-omic technologies for clinical translation. To support coordinated data integration across distributed research sites, we developed a common Consortium Data Model in partnership with domain experts to standardize the capture of participant-, family-, phenotype- and assay-level metadata, with a particular emphasis on using a modular architecture to support linking of multiple data versions from multiple omic technologies to a single individual and attribution of a genetic finding to the specific technology used for its initial discovery. Adoption of the GREGoR Data Model has enabled continued generation and public release of a harmonized, analysis-ready Consortium Dataset. The most recent release includes phenotypic, family and multi-omic data from 12,292 participants in 5,029 families. Other rare disease data sharing efforts are beginning to adopt this data model which will facilitate cross consortium analyses and empower rare disease research. This work demonstrates that a collaborative, flexible, and scalable data model can enable large-scale rare disease research, facilitate cross-center data harmonization, and enable data interoperability.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A unified data infrastructure to support large-scale rare disease research
Lennart F. Johansson, Steven Laurie, … Anthony J. Brookes·medRxiv·Dec 20, 2023
- RD-OMICS: An Integrative Multi-Omics Data Inventory in Rare Diseases
Huanfei Wang, Shixue Sun, … Qian Zhu·bioRxiv·Jul 3, 2026
- Linking international registries to FHIR and Phenopackets with RareLink: a scalable REDCap-based framework for rare disease data interoperability
Adam S L Graefe, Filip Rehburg, … Oya Beyan·medRxiv·May 9, 2025
- FHIR as a Unifying Format for Genomic Research Data Tracking, Aggregation, and Integration
Nasim Sanati, Brian Walsh, … Kyle Ellrott·bioRxiv·Dec 24, 2025
- Dissecting the functional landscape of rare diseases through genomic variation in a heterogeneous cohort of 11,000 patients
Graciela Uría-Regojo, Lidia Fernández‐Caballero, … Pablo Mínguez·medRxiv·Jul 14, 2026
- Genomic Research as a Critical Pathway to Diagnosis for Individuals with Rare Disease
Anne O’Donnell‐Luria, Stephanie P. DiTroia, … Heidi L. Rehm·medRxiv·Sep 20, 2026